What is the market doing?
What the tape says about MBX
MBX Biosciences, Inc. is +501% over the past year while the S&P 500 is +23%: 478 points ahead of the market.
+501%
1-year return · S&P 500 +23%
- vs 200-day average
- +81%
vs 200-day average · a clear uptrend
- RSI (14)
- 50
RSI (14) · neutral
- Below its 52-week high
- −5.4%
Below its 52-week high
Details›
- Last close2026-08-26
- $66.87
- 1 monthS&P 500 +3.7%
- +5.2%
- 1 yearS&P 500 +23%
- +501%
- vs 50-day average$53.88
- +24%
- 52-week high
- $70.67
- 52-week low
- $9.74
- Annualised volatility
- 117%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $501K
| Year | Return |
|---|---|
| 2026 (year to date) | +112% |
| 2025 | +71% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.